Mass spectrometric analyses for crystallins. by Akosua K. Boateng (21672931)

Subjects:

RNA-seq data showing top 15 downregulated genes. by Akosua K. Boateng (21672931)

Subjects:

RNA-seq data showing top 15 upregulated genes. by Akosua K. Boateng (21672931)

Subjects:

The (A) logistic regression model (LRM) and (B) random forest model (RFM) with only conservation scores as independent variables (orange, yellow) show decreased model fitting metri... by Bushra Haque (20513785)

Prioritising public information leads to increases in network connectivity, but is generally lower than when private information is prioritised. by Adam Lee Miles (14123916)

Subjects:

EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

RCS analysis of the association between Log-dNLR and all-cause mortality among subgroups. by Jun Ma (9393)

Subjects:

Serial passage of LACV in the presence of increasing NHC concentrations to select for resistance. by Durbadal Ojha (475076)

Data Sheet 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.…”

Data Sheet 4_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.…”

Data Sheet 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.…”

Data Sheet 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.…”

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients.... by Emir Matpan (21655811)

“…<p>Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. …”

Oligonucleotide primers for gene expression. by Cian Reid (17274007)

“…In response to TLR ligands LPS, Pam3CSK4 and R848, protein analysis of supernatant collected from all calves with BRD revealed significantly increased IL-6, but not IL-1β or IL-8, compared to healthy controls. …”

Calf health information. by Cian Reid (17274007)

“…In response to TLR ligands LPS, Pam3CSK4 and R848, protein analysis of supernatant collected from all calves with BRD revealed significantly increased IL-6, but not IL-1β or IL-8, compared to healthy controls. …”

Kaplan-Meier curves for UHR quartile classification (A: all-cause mortality, B: cardiovascular mortality). by Chunyu Yan (9627588)

Subjects:

Sensitive analysis plot of the relationship between initial insomnia and risk of all-cause dementia. by Mingxian Meng (21029668)

Forest plot of the relationship between early morning awakening and risk of all-cause dementia. by Mingxian Meng (21029668)

Forest plot of the relationship between sleep-maintenance insomnia and risk of all-cause dementia. by Mingxian Meng (21029668)

Eligibility criteria. by Keean Nanji (16516622)

“…Data will be collected and synthesized for seven pre-specified outcomes at 6 weeks and 3 months following surgery: i) change in central retinal thickness measured by optical coherence tomography (OCT), ii) best-recorded visual acuity iii) the rate of CME measured by OCT, and fluorescein angiography (FA) iv) the rate of patients experiencing clinically significant macular edema defined as the presence of CME and pre-specified thresholds for decreased visual acuity, v) patient quality of life, vi) intraocular pressure and vii) the number of patients experiencing one or more pre-specified adverse events. …”